A cancer drug is in development that could stop the disease in its tracks.
The unnamed medication targets a specific enzyme that fuels the spread of tumours, new research reveals.
It does this by binding to the membrane of rapidly multiplying cells, a European study found.
This hijacks cancer's 'survival mechanism' and prevents tumours from attaching to the protein they need to thrive.
Around 357,000 people get diagnosed with cancer every year in the UK.
- Medication targets a specific enzyme that fuels the spread of tumours.
- It does this by binding to the membrane of rapidly multiplying cells.
- This hijacks cancer's 'survival mechanism' and prevents tumours from thriving.
- It is unclear when the drug, which is unnamed, may be available for patients.
- Around 357,000 people get diagnosed with cancer every year in the UK.
